Crossref

1. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

- Andrew A. Li

- Aijaz Ahmed

- Donghee Kim

2. Hepatic fat infiltration and clinical indicators in polycystic ovary syndrome: insights from MRI HISTO sequences

- Min Ling

- Shuting Lu

- Runrong Chen

- Jiangnian Gong

- Bin Tian

- Yingfen Qin

- Jia Zhou

- Zisan Zeng

3. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial

- Signe Frøssing

- Malin Nylander

- Elizaveta Chabanova

- Jan Frystyk

- Jens J. Holst

- Caroline Kistorp

- Sven O. Skouby

- Jens Faber

4. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease

- Nicolás Salva-Pastor

- Norberto C. Chávez-Tapia

- Misael Uribe

- Natalia Nuño-Lámbarri

5. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance

- Thomas M Barber

- George K Dimitriadis

- Avgi Andreou

- Stephen Franks

6.

7. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

- Mary E. Rinella

- Brent A. Neuschwander-Tetri

- Mohammad Shadab Siddiqui

- Manal F. Abdelmalek

- Stephen Caldwell

- Diana Barb

- David E. Kleiner

- Rohit Loomba

8. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies

- Thomas M Barber

- Petra Hanson

- Martin O Weickert

- Stephen Franks

9. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones

- Sara Arefhosseini

- Mehrangiz Ebrahimi-Mameghani

- Farzad Najafipour

- Helda Tutunchi

10. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database

- Balachandran Kumarendran

- Michael W. O’Reilly

- Konstantinos N. Manolopoulos

- Konstantinos A. Toulis

- Krishna M. Gokhale

- Alice J. Sitch

- Chandrika N. Wijeyaratne

- Arri Coomarasamy

- Wiebke Arlt

- Krishnarajah Nirantharakumar

- Jenny E Myers

11. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS

- Salvatore Petta

- Alessandro Ciresi

- Jessica Bianco

- Vincenzo Geraci

- Roberta Boemi

- Luigi Galvano

- Franco Magliozzo

- Giovanni Merlino

- Antonio Craxì

- Carla Giordano

- Andrew Wolfe

12. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025

- E. Roeb

- A. Canbay

- H. Bantel

- J. Bojunga

- J. de Laffolie

- M. Demir

- U. W. Denzer

- A. Geier

- W. P. Hofmann

- C. Hudert

- T. Karlas

- M. Krawczyk

- T. Longerich

- T. Luedde

- M. Roden

- J. Schattenberg

- M. Sterneck

- A. Tannapfel

- P. Lorenz

- F. Tacke

13. New approaches to early detection of polycystic ovary syndrome in obese women

- V.V. Artyomenko

- V.I. Velychko

- D.O. Lahoda

14. Nonalcoholic fatty liver disease shows significant sex dimorphism

- Xing-Yu Chen

- Cong Wang

- Yi-Zhou Huang

- Li-Li Zhang

15. Metabolic Syndrome in Polycystic Ovary Syndrome

- Yun-Chiao Hsieh

- Po-Kai Yang

- Mei-Jou Chen

16. Association between Poly Cystic Ovaries and Non-Alcoholic Fatty Liver Disease in Young Females on Ultrasonography

- Tehreem Malik

- Akash John

- Abid Ali

- Muhammad Ahmad Naeem

17. Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome

- Mohammad Maysara Asfari

- Muhammad Talal Sarmini

- Firas Baidoun

- Yasser Al-Khadra

- Yamen Ezaizi

- Srinivasan Dasarathy

- Arthur McCullough

18. Endocrine causes of nonalcoholic fatty liver disease

- Laura Marino

19. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges

- Yvonne M. Jeanes

- Sue Reeves

20.

21. Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications

- Ana-Maria Singeap

- Carol Stanciu

- Laura Huiban

- Cristina Maria Muzica

- Tudor Cuciureanu

- Irina Girleanu

- Stefan Chiriac

- Sebastian Zenovia

- Robert Nastasa

- Catalin Sfarti

- Camelia Cojocariu

- Anca Trifan

- Branka Filipović

22. Caring for children with NAFLD and navigating their care into adulthood

- Ali A. Mencin

- Rohit Loomba

- Joel E. Lavine

23. Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin

- Myeong Jun Song

- Jong Young Choi

24. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?

- Giovanni Targher

- Maurizio Rossini

- Amedeo Lonardo

25. Polycystic ovary syndrome: approach to correction of metabolic disorders

- Л. В. Калугіна

- Т. Ф. Татарчук

26. The Relationship Between Metabolic Syndrome and PCOS: A Review for the Obstetrician/Gynecologist

- Schuyler Hodge

- Nicole M. Marchetto

- Sara S. Morelli

27. Polycystic Ovary Syndrome and Medical Conditions

- NANETTE L. ROLLENE

- JESSICA A. LENTSCHER

- ASHLEIGH M. HEMPHILL

- ALAN H. DECHERNEY

28.

29. NAFLD Associated Comorbidity

- L. B. Lazebnik

- S. V. Turkina

30. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome

- Stavroula A. Paschou

- Stergios A. Polyzos

- Panagiotis Anagnostis

- Dimitrios G. Goulis

- Christina Kanaka-Gantenbein

- Irene Lambrinoudaki

- Neoklis A. Georgopoulos

- Andromachi Vryonidou

31.

32. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction

- Vincenza Di Stasi

- Elisa Maseroli

- Giulia Rastrelli

- Irene Scavello

- Sarah Cipriani

- Tommaso Todisco

- Sara Marchiani

- Flavia Sorbi

- Massimiliano Fambrini

- Felice Petraglia

- Mario Maggi

- Linda Vignozzi

33. Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome

- Iliana Doycheva

- David A. Ehrmann

34. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis

- A. L. L. Rocha

- L. C. Faria

- T. C. M. Guimarães

- G. V. Moreira

- A. L. Cândido

- C. A. Couto

- F. M. Reis

35. Obesity and polycystic ovary syndrome

- Thomas M. Barber

- Stephen Franks

36. Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women

- Nidhi Makhija

- Surekha Tayade

- Shikha Toshniwal

- Hard Tilva

37.

38.

39.

40. Medical treatment and comorbidity in polycystic ovary syndrome: An updated review

- Dorte Glintborg

- Marianne Andersen

41. Endocrinology update

- Christopher Redford

- Antonia Brooke

42. Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women

- Sujata Siwatch

- Virendra Singh

- Lakhbir K. Dhaliwal

- Sunita Kumari

- Kartar Singh

43. NAFLD: comorbidity and associated diseases

- M. A. Livzan

- O. V. Gaus

- N. A. Nikolaev

- T. S. Krolevetz

44. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance

- Thomas M Barber

- George K Dimitriadis

- Avgi Andreou

- Stephen Franks

45. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

- Lisa B. VanWagner

- Mary E. Rinella

46. Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography

- Claruza Braga Holanda Lavor

- Antonio Brazil Viana Júnior

- Francisco das Chagas Medeiros

47. An integrated multidisciplinary model of care for addressing comorbidities beyond reproductive health among women with polycystic ovary syndrome in India

- Anushree Devashish Patil

- Rama Ashok Vaidya

- Shahina Begum

- Sanjay L. Chauhan

- Srabani Mukherjee

- Pratibha P. Kokate

- Beena Nitin Joshi

48. A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis

- Jia Wu

- Xin-Yu Yao

- Ru-Xia Shi

- Su-Fen Liu

- Xiao-Yong Wang

49. Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?

- Na Di

- Xinchuan Zhou

- Yaxiao Chen

- Xiaomiao Zhao

- Lin Li

- Linlin Jiang

- Baoming Luo

- Xiaoli Chen

- Dongzi Yang

50.

51. Therapeutic pipeline in nonalcoholic steatohepatitis

- Raj Vuppalanchi

- Mazen Noureddin

- Naim Alkhouri

- Arun J. Sanyal

52. Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review

- Raseen Tariq

- Page Axley

- Ashwani K. Singal

53. Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025

54. Using machine learning to predict patients with polycystic ovary disease in Chinese women

- Chen-Yu Wang

- Dee Pei

- Chun-Kai Wang

- Jyun-Cheng Ke

- Siou-Ting Lee

- Ta-Wei Chu

- Yao-Jen Liang

55. Non‐alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta‐analysis

- Mohamed Shengir

- Tianyan Chen

- Elena Guadagno

- Agnihotram V Ramanakumar

- Peter Ghali

- Marc Deschenes

- Philip Wong

- Srinivasan Krishnamurthy

- Giada Sebastiani

56. Beyond fertility: polycystic ovary syndrome and long-term health

- Laura G. Cooney

- Anuja Dokras

57. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis

- Aikaterini Lavrentaki

- Tom Thomas

- Anuradhaa Subramanian

- George Valsamakis

- Neil Thomas

- Konstantinos A. Toulis

- Jingya Wang

- Barbara Daly

- Ponnusamy Saravanan

- Dana Sumilo

- George Mastorakos

- Abd A. Tahrani

- Krishnarajah Nirantharakumar

58. Electroacupuncture Versus Aerobic Interval Training on Liver Functions in Patients with Nonalcoholic Fatty Liver

- Ramy Salama Draz

- Zahra M.H. Serry

- Awny Fouad Rahmy

- Maha saber El Bardesi

- Mona Mohamed Taha

59. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non‐obese non‐alcoholic fatty liver disease

- J. J. Kim

- D. Kim

- J. Y. Yim

- J. H. Kang

- K. H. Han

- S. M. Kim

- K. R. Hwang

- S. Y. Ku

- C. S. Suh

- S. H. Kim

- Y. M. Choi

60.

61.

62. Biochemical, sex hormonal, and anthropometric predictors of non-alcoholic fatty liver disease in polycystic ovary syndrome

- Xintong Li

- Min Min

- Fangfang Duan

- Xiangyan Ruan

- Li Xu

63. Female infertility, infertility-associated diagnoses, and comorbidities: a review

- Brent Hanson

- Erica Johnstone

- Jessie Dorais

- Bob Silver

- C. Matthew Peterson

- James Hotaling